1. Market Research
  2. > Healthcare
  3. > Blood Supply, Tissue Banking and Transplantation Market Trends
  4. > Complete 2015-16 Global Cord Blood Banking Industry Report

Complete 2015-16 Global Cord Blood Banking Industry Report

  • August 2015
  • -
  • BioInformant Worldwide, L.L.C.
  • -
  • 204 pages


Table of Contents

This 204 page global strategic report is a must-read document for cord blood banking executives and investors In addition to containing market size, segments, trends, and projections through 2020, it contains a 40-question, 52-page survey of 600+ recent and expectant parents worldwide Additionally, BioInformant has been tracking the cord blood banking industry for a decade (2006 to present) using dashboards of key industry metrics, combined with a system of alerts that identify unexpected variation

The global cord blood banking industry has matured substantially over the past few years, creating both serious threats and novel opportunities

Serious threats to the industry include:

New accreditation requirements that have increased the cost structure of cord blood banks
A decline in cord blood transplants, within the US and other geographical regions
Low rates of turnover for stored cord blood units
Expensive cord blood transplantation procedures, costing from $200-300K each
Difficulty with educating obstetricians about cellular therapies
Poor press coverage in many regions worldwide, including major news outlets
Other uncontrollable factors that could threaten the industry include: new legislation, changes in transplant reimbursement, continually evolving accreditation requirements, the potential for competitive approaches to be shown as more optimal, patent challenges for processing or transplant technologies, changes in public perception of private vs public banking, shift in policy recommendations by influential medical organizations, and changes in government support

Marketing pressures are also impacting the industry, with the term “cord blood” becoming one of the 20 most expensive search terms on Google, reaching more than $20 per click for global search traffic and close to $40 per click for US search traffic

However, there are also emerging opportunities, including:

The potential to expand market size through increasing public awareness
New clinical trial data supporting applications for hematopoietic stem cells (HSCs) from cord blood and mesenchymal stem cells (MSCs) from cord tissue
Improving public perception toward stem cell therapies
Substantial deal-making within the industry, including mergers, acquisitions, and funding rounds
The potential for cross-organizational collaboration through formation of Cord Blood Industry Associations (occurring in within US and South America)
A trend toward diversification within the industry, with cord blood banks effectively becoming stem cell banks through the storage of cord blood, cord tissue, and in some cases, placental tissue, amniotic fluid, and more
Within this rapidly evolving ecosystem, those who choose to commit to understanding current opportunities and threats will be positioned for a substantial strategic advantage

A Global Market Requires Global Understanding

While these factors vary somewhat by market, there is a substantial advantage to having a global understanding of the market You need to understand successes and failures by region to be fully informed of your competitive environment You need to have a firm understanding of emerging trends that could expand to new regions and impact your business model In addition, research advances, clinical trial findings, and technology advances do not know international boundaries They are shared nearly instantly from region-to-region

The cord blood market is global in nature and understanding dynamics limited to your region is not sufficient for making strategic, informed, and profitable decisions

Furthermore, cord blood banks now exist in every developed country, as well as within most developing nations With approximately 500 cord blood banks operating worldwide, maturation of the global cord blood market means that each cord blood bank is now fighting harder for market share

Key Report Findings

The report is designed to guide the decision-making of cord blood banks worldwide, as well as to advise private, corporate, and institutional investors entering into this market

As such, it considers a range of metrics that impact the global cord blood banking market It includes trend rate data for cord blood clinical trials, patents, grants, scientific publications and more For instance, there are now more than 500 studies involving cord blood listed on wwwClinicalTrialsgov, and there have been hundreds of patents related to cord blood collection, processing, and storage filed through the United States Patent and Trademark Office (wwwUSPTOgov) Globally, this patent count is even larger

Additionally, the year-over-year increase in scientific publications on PubMedgov containing the term “cord blood” has been increasing PubMedgov is a global database of scientific publications containing more than 24 million citations for biomedical literature, which makes it an excellent resource for gauging biomedical research trends However, grant rate data reveals that funding for cord blood related research has been declining from 2012 to present

BioInformant also analyzes the types of investments being made within the cord blood marketplace, including investments made by:

ABS Capital Partners & HLM Management
KKR & Company
Bay City Capital

Key report findings include:

Market size determinations for the global cord blood market
Trend rate data for umbilical cord blood grants, patents, and scientific publications
Clinical trial rate analysis, including comparison of cord blood vs cord tissue frequency
Rates of global cord blood storage (units per year)
Rates of global cord blood transplant (units per year)
Current and future conditions treatable with cord blood
Probability of requiring a stem cell transplant by age
Trends in medical opinions of cord blood banking
Changes in legislative support for cord blood banking
Investors impacting the global cord blood banking marketplace
Competitive environment analysis, including assessment of cord blood market leaders
Influential alliances within the cord blood industry
“SWOT” analysis for global cord blood industry (Strengths, Weaknesses, Opportunities, Threats)
Crucial trends and unmet market needs

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Animal Blood Plasma Products and Derivatives Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024

Animal Blood Plasma Products and Derivatives Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • March 2017
  • by Transparency Market Research

Animal Blood Plasma Products and Derivatives Market (Derivatives Type - Immunoglobulin, Fibrinogen, Serum Albumin, and Fetal Bovine Serum; Application - Cell Culture Media, Food Industry, Pharmaceutical ...

Blood Screening Market by Technology, ELISA,, Rapid Test, NGS, Western Blotting), Product & End User - Global Forecasts to 2021

Blood Screening Market by Technology, ELISA,, Rapid Test, NGS, Western Blotting), Product & End User - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The blood screening market is expected to reach USD 2.80 billion by 2021 from USD 1.76 billion in 2016, at a CAGR of 9.7%. The global blood screening market is categorized based on technology, product ...

Apheresis Market by Product, Procedure, Application, Technology - Global Forecast to 2021

Apheresis Market by Product, Procedure, Application, Technology - Global Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.